Document:

exv10w1

 

Exhibit 10.1

SETTLEMENT AGREEMENT

     1. This Settlement Agreement is made by and between Fairchild Semiconductor Corporation
(“Fairchild”) and Amkor Technology, Inc. (“Amkor”).

     2. Fairchild filed an action against Amkor in the Superior Court of California, County of
Santa Clara, Case No. 1-02-CV-810034 (the “Action”). Fairchild and Amkor hereby agree that they
will execute and file all papers necessary to accomplish the dismissal with prejudice of all claims
by Fairchild against Amkor in the Action within five (5) business days of the execution of this
Agreement. Each party will bear its own attorney’s fees and costs incurred in the Action.

     3. Fairchild, for itself and its legal successors and assigns, agents, employees,
representatives, officers, directors, parent, subsidiary or affiliated corporations, and each of
them, hereby releases Amkor and its legal successors and assigns, agents, employees,
representatives, officers, directors, parent, subsidiary or affiliated corporations, and each of
them, from and against any and all claims, actions, causes of action, liabilities and demands,
whether known or unknown, that were raised or could have been raised in the Action, or in any way
relate to the Action, or relate in any manner to the use of a phosphorus-containing epoxy molding
compound in any product assembled by Amkor for Fairchild (collectively the “Fairchild Claims”).

     4. Amkor, for itself and its legal successors and assigns, agents, employees, representatives,
officers, directors, parent, subsidiary or affiliated corporations, and each of them, hereby
releases Fairchild and its legal successors and assigns, agents, employees, representatives,
officers, directors, parent, subsidiary or affiliated corporations, and each of them, from and
against any and all claims, actions, causes of action, liabilities and demands, whether known or
unknown, that were raised or could have been raised in the Action, or in any way relate to the

-1-

 

Action, or relate in any manner to the use of a phosphorus-containing epoxy molding compound
in any product assembled by Amkor for Fairchild.

     5. The parties acknowledge that both known and unknown claims are covered by this Settlement
Agreement, and waive any rights or benefits that may arise under California Civil Code § 1542,
which provides as follows:

A general release does not extend to claims which the creditor does not
know or suspect to exist in his favor at the time of executing the
release, which if known by him must have materially affected his
settlement with the debtor.

     6. Amkor shall pay to Fairchild within thirty (30) days of the date of execution of this
Agreement the sum of three million dollars (USD $3,000,000). Said payment shall be made by wire
transfer to the following account:

	 	 	 	 	 
	 

	 	Beneficiary Bank:
	 	[****]
	 

	 	ABA:
	 	[****]
	 

	 	Beneficary Name:
	 	Fairchild Semiconductor
	 

	 	Beneficiary Account:
	 	[****]

     7. This Settlement Agreement does not address or affect Fairchild’s claims against Sumitomo
Bakelite Singapore Pte. Ltd., Sumitomo Plastics America, Inc. or Sumitomo Bakelite Co., Ltd.
(collectively “Sumitomo Bakelite”).

     8. Fairchild warrants and represents that it has not assigned and that it will not assign any
Fairchild Claim it has or may have against Amkor to any other party.

     9. Concurrent with the execution of this Settlement Agreement, Amkor will enter into a written
agreement with Sumitomo Bakelite in which Sumitomo Bakelite agrees not to remove the Action to
federal court by reason of this Settlement Agreement. The terms of this Settlement Agreement are
not operable unless Sumitomo agrees in writing not to remove the

-2-

 

Action. Amkor shall provide Fairchild with a copy of the fully-executed agreement with
Sumitomo.

     10. Nothing in this Settlement Agreement shall constitute or be treated as an admission of
liability or wrongdoing by any party. Nothing in this Settlement Agreement shall be admissible in
any future dispute, except in an action to enforce this Settlement Agreement.

     11. The parties agree that they will not issue any press release disclosing this settlement or
its terms, and will in good faith refrain from disclosing the terms of the settlement to anyone
other than their attorneys, insurance carriers, accountants, or other persons in the business or
financial community with whom the party has regular communications regarding the party’s financial
condition. Each party is specifically permitted to disclose the settlement and its terms in a Form
8-K, 10-Q or 10-K filing or other financial disclosure required by law. Fairchild and Amkor agree
that they shall each have an opportunity to review and comment upon any Form 8-K to be issued by
the other regarding the settlement memorialized in this Settlement Agreement.

     12. This Settlement Agreement shall be governed, construed and enforced in accordance with the
laws of the State of California without regard to principles of choice of law or conflicts of law.

     13. The Parties agree that the Honorable Jack Komar of the Santa Clara County Superior Court,
or such other judge as may be assigned from the Santa Clara County Superior Court, shall retain
jurisdiction for purposes of enforcement and/or dispute resolution concerning this Settlement
Agreement.

     14. This Settlement Agreement is an integrated document which states the entire agreement
between Fairchild and Amkor. Each of Fairchild and Amkor affirms and

-3-

 

acknowledges that it has executed this Settlement Agreement voluntarily and without coercion,
that it has not relied on any prior or contemporaneous written or oral representations extrinsic or
collateral to the terms of this Settlement Agreement, and that it has obtained legal advice from
its attorneys in entering into this Settlement Agreement. This Settlement Agreement shall be
deemed to have been drafted jointly by Fairchild and Amkor, and neither Fairchild nor Amkor shall
be treated as having drafted the agreement for purposes of construction.

     15. Each of Fairchild and Amkor warrants that the individual signing this Settlement Agreement
on its behalf has full authority to do so and that it intends to be bound by the signature of the
individual it designates to sign this Settlement Agreement.

     16. This Settlement Agreement may be executed in counterparts, but all such counterparts shall
constitute but one agreement. In addition, this Settlement Agreement may be executed via
signatures transmitted by facsimile, and such signatures shall be deemed in all respects the same
as original signatures.

-4-

 

     IN WITNESS WHEREOF, the undersigned have executed this Settlement Agreement on the day and the
year written below.

	 	 	 
	Dated: August 5, 2005

	 	FAIRCHILD SEMICONDUCTOR CORPORATION
	 
	 	 
	 

	 	By: /s/
	 
	 	 
	 

	 	Name: Paul D. Delva
	 
	 	 
	 

	 	Title: Vice President, General Counsel
	 
	 	 
	Dated: August 5, 2005

	 	AMKOR TECHNOLOGY, INC.
	 
	 	 
	 

	 	By: /s/
	 
	 	 
	 

	 	Name: Jerry C. Allison
	 
	 	 
	 

	 	Title: Vice President and Asst. General Counsel

-5-<PAGE>

                                                                    EXHIBIT 4.1

===============================================================================

                                                                 EXECUTION COPY

                            TECUMSEH PRODUCTS COMPANY

                                 AMENDMENT NO. 3
                           TO NOTE PURCHASE AGREEMENT

                          DATED AS OF NOVEMBER 4, 2005

     $300,000,000 ADJUSTABLE RATE SENIOR GUARANTEED NOTES DUE MARCH 5, 2011

===============================================================================

<PAGE>

                            TECUMSEH PRODUCTS COMPANY

     $300,000,000 ADJUSTABLE RATE SENIOR GUARANTEED NOTES DUE MARCH 5, 2011

                                                         As of November 4, 2005

TO EACH OF THE CURRENT NOTEHOLDERS
NAMED IN ANNEX 1 HERETO:

Ladies and Gentlemen:

         TECUMSEH PRODUCTS COMPANY, a Michigan corporation (together with any
successors and assigns, the "COMPANY"), hereby agrees with each of you as
follows:

1.       PRIOR ISSUANCE OF NOTES, ETC.

         The Company is a party to a certain Note Purchase Agreement dated as of
March 5, 2003 with the purchasers named in Schedule A thereto, as amended by
that certain Amendment and Waiver No. 1 to Note Purchase Agreement (the "FIRST
AMENDMENT AGREEMENT") dated as of June 30, 2005, and that certain Amendment No.
2 to Note Purchase Agreement (the "SECOND AMENDMENT AGREEMENT") dated as of
August 5, 2005 (as amended by the First Amendment Agreement and the Second
Amendment Agreement, the "EXISTING NOTE PURCHASE AGREEMENT" and, as amended
pursuant to this Agreement and as may be further amended, restated or otherwise
modified from time to time, the "NOTE PURCHASE AGREEMENT") pursuant to which the
Company issued and sold three hundred million dollars ($300,000,000) in
aggregate principal amount of its 4.66% Senior Guaranteed Notes due March 5,
2011, which Notes were amended pursuant to the Second Amendment Agreement to be
the Company's Adjustable Rate Senior Guaranteed Notes due March 5, 2011 (as
amended, restated, modified or replaced from time to time, together with any
such notes issued in substitution therefor pursuant to Section 13 of the Note
Purchase Agreement, the "NOTES"). The Company represents and warrants to each of
you that the register kept by the Company for the registration and transfer of
the Notes indicates that each of the Persons named in Annex 1 hereto
(collectively, the "CURRENT NOTEHOLDERS") is currently a holder of the aggregate
principal amount of the Notes indicated in such Annex.

2.       REQUEST FOR CONSENT TO AMENDMENTS.

         The Company requests that each of the Current Noteholders agree to the
amendment of certain provisions of the Existing Note Purchase Agreement as
provided for by Section 4 of this Agreement (the "AMENDMENTS").

3.       WARRANTIES AND REPRESENTATIONS.

         To induce the Current Noteholders to enter into this Agreement and to
agree to the Amendments, the Company warrants and represents to you, as of the
Effective Date, as follows (it being agreed, however, that nothing in this
Section 3 shall affect any of the warranties and representations previously made
by the Company in or pursuant to the Existing Note Purchase

<PAGE>

Agreement, and that all of such other warranties and representations, as well as
the warranties and representations in this Section 3, shall survive the
effectiveness of the Amendments).

         3.1.     NO MATERIAL ADVERSE CHANGE.

         Since the date of the financial statements of the Company filed with
the Securities and Exchange Commission with the Company's Quarterly Report on
Form 10-Q for the period ended June 30, 2005 (the "Second Quarter 2005 Financial
Statements"), there has been no change in the business operations, profits,
financial condition, properties or business prospects of the Company except for
an approximate $25 million reduction in profits and assets resulting from the
establishment by the Company, during the fiscal quarter ended September 30,
2005, of a valuation allowance against deferred tax assets, as contemplated in
footnote 11 to the Second Quarter 2005 Financial Statements, and except for
changes that, in the aggregate, could not reasonably be expected to have a
Material Adverse Effect.

         3.2.     FULL DISCLOSURE.

         Neither the financial statements and other certificates previously
provided to the Current Noteholders pursuant to the provisions of the Existing
Note Purchase Agreement nor the statements made in this Agreement nor the
materials and information furnished by or on behalf of the Company to the
Current Noteholders in connection with the proposal and negotiation of the
Amendments, taken as a whole, contain any untrue statement of a material fact or
omit a material fact necessary to make the statements contained therein and
herein, taken as a whole, not misleading. There is no fact relating to any event
or circumstance that has occurred or arisen since August 5, 2005 that the
Company has not disclosed to the Current Noteholders in writing that has had or,
so far as the Company can now reasonably foresee, could reasonably be expected
to have, a Material Adverse Effect. All pro forma financial information,
financial or other projections and forward-looking statements delivered to the
Current Noteholders have been prepared in good faith by the Company based on
reasonable assumptions.

         3.3.     SOLVENCY.

         The fair value of the business and assets of each of the Company and
each Subsidiary Guarantor exceeds the amount that will be required to pay its
respective liabilities (including, without limitation, contingent, subordinated,
unmatured and unliquidated liabilities on existing debts, as such liabilities
may become absolute and matured). Neither the Company nor the Subsidiary
Guarantors is engaged in any business or transaction, or about to engage in any
business or transaction, for which such Person has unreasonably small assets or
capital (within the meaning of the Uniform Fraudulent Transfer Act, the Uniform
Fraudulent Conveyance Act and Section 548 of the Federal Bankruptcy Code), and
neither the Company nor the Subsidiary Guarantors has any intent to

                  (a)      hinder, delay or defraud any entity to which any of
         them is, or will become, on or after the Effective Date, indebted, or

                  (b)      incur debts that would be beyond any of their ability
         to pay as they mature.

<PAGE>

         3.4.     NO DEFAULTS.

         No event has occurred and no condition exists that, upon the execution
and delivery of this Agreement and the effectiveness of the Amendments, would
constitute a Default or an Event of Default.

         3.5.     NO BANKRUPTCY FILING.

         Neither the Company nor any Subsidiary (a) is contemplating either an
Insolvency Proceeding with respect to it or the liquidation of all or a major
portion of its assets or property following the Effective Date and (b) has any
knowledge of any Person contemplating an Insolvency Proceeding against it. As
used herein, the term "Insolvency Proceeding" means any proceeding commenced by
or against any Person under any provision of the United States Federal
Bankruptcy Code or under any other bankruptcy or insolvency law, assignments for
the benefit of creditors, formal or informal moratoria, compositions, or
extensions generally with creditors, or proceedings seeking reorganization,
arrangement, or other similar relief.

         3.6.     TITLE TO PROPERTIES.

         The Company and its Subsidiaries have good and sufficient title to or
the legal right to use their respective properties that individually or in the
aggregate are Material, including all such properties reflected in the most
recent audited balance sheet of the Company delivered pursuant to the provisions
of Section 7.1 of the Existing Note Purchase Agreement (except as sold or
otherwise disposed of in the ordinary course of business) or purported to have
been acquired by the Company or any Subsidiary after said date (except as sold
or otherwise disposed of in the ordinary course of business), in each case free
and clear of Liens not permitted by the Note Purchase Agreement.

         3.7.     TRANSACTION IS LEGAL AND AUTHORIZED; OBLIGATIONS ARE
                  ENFORCEABLE.

                  (a)      The execution and delivery of this Agreement by the
         Company and compliance by the Company with all of its respective
         obligations hereunder:

                           (i)      is within the corporate powers of the
                                    Company;

                           (ii)     is legal and does not conflict with, result
                  in any breach in any of the provisions of, constitute a
                  default under, or result in the creation of any Lien upon any
                  Property of the Company or any Subsidiary under the provisions
                  of, any agreement, charter instrument, bylaw or other
                  instrument to which it is a party or by which it or any of its
                  Property may be bound; and

                           (iii)    does not give rise to a right or option of
                  any other Person under any agreement or other instrument,
                  which right or option could reasonably be expected to have a
                  Material Adverse Effect.

                  (b)      This Agreement has been duly authorized by all
         necessary action on the part of the Company and has been executed and
         delivered by one or more duly authorized officers of the Company, and
         each constitutes a legal, valid and binding obligation of the

<PAGE>

         Company, enforceable in accordance with its terms, except that such
         enforceability may be:

                           (i)      limited by applicable bankruptcy,
                  reorganization, arrangement, insolvency, moratorium or other
                  similar laws affecting the enforceability of creditors' rights
                  generally; and

                           (ii)     subject to the availability of equitable
                  remedies.

         3.8.     CERTAIN LAWS.

         The execution and delivery of this Agreement by the Company and the
consummation of the transaction contemplated hereby:

                  (a)      is not subject to regulation under the Investment
         Company Act of 1940, as amended, the Public Utility Holding Company Act
         of 1935, as amended, the Transportation Acts, as amended, or the
         Federal Power Act, as amended, and

                  (b)      does not violate any provision of any statute or
         other rule or regulation of any Governmental Authority applicable to
         the Company or any Subsidiary.

         3.9.     LITIGATION; OBSERVANCE OF AGREEMENTS.

                  (a)      Other than the matters disclosed in the consolidated
         financial statements of the Company and its Subsidiaries for the fiscal
         year ended December 31, 2004 and the fiscal quarters ended March 31,
         2005 and June 30, 2005 (and the footnotes thereto), there are no
         actions, suits or proceedings pending or, to the knowledge of the
         Company, threatened against or affecting the Company or any Subsidiary
         or any property of the Company or any Subsidiary in any court or before
         any arbitrator of any kind or before or by any Governmental Authority
         that, individually or in the aggregate, could reasonably be expected to
         have a Material Adverse Effect.

                  (b)      Other than the matters disclosed in the consolidated
         financial statements of the Company and its Subsidiaries for the fiscal
         year ended December 31, 2004 and the quarters ended March 31, 2005 and
         June 30, 2005 (and the footnotes thereto), neither the Company nor any
         Subsidiary is in default under any term of any order, judgment, decree
         or ruling of any court, arbitrator or Governmental Authority or is in
         violation of any applicable law, ordinance, rule or regulation
         (including, without limitation, Environmental Laws) of any Governmental
         Authority, which default or violation, individually or in the
         aggregate, could reasonably be expected to have a Material Adverse
         Effect.

         3.10.    CHARTER INSTRUMENTS; OTHER AGREEMENTS.

         Neither the Company nor any Subsidiary is in violation in any respect
of any term of any charter instrument or bylaw. Upon the execution and delivery
hereof and the effectiveness of the Amendments as provided herein, neither the
Company nor any Subsidiary is in violation or default in any material respect of
any term in any agreement or other instrument to which it is a

<PAGE>
party or by which it or any of its material property may be bound or affected.
The execution, delivery and performance by the Company of this Agreement will
not conflict with or result in the breach of any of the terms, conditions or
provisions of any order, judgment, decree or ruling of any court, arbitrator or
Governmental Authority applicable to the Company or any Subsidiary or violate
any provision of any statute or other rule or regulation of any Government
Authority applicable to the Company or any Subsidiary. The Company represents
that the Specified IRB Documents will be amended to conform certain terms
thereof to the terms of the Credit Agreement, but no other material amendments
to the Specified IRB Documents will be made.

         3.11.    TAXES.

         The Company and its Subsidiaries have filed all tax returns that are
required to have been filed in any jurisdiction, and have paid all taxes shown
to be due and payable on such returns and all other taxes and assessments levied
upon them or their properties, assets, income or franchises, to the extent such
taxes and assessments have become due and payable and before they have become
delinquent, except for any taxes and assessments (a) the amount of which is not
individually or in the aggregate Material or (b) the amount, applicability or
validity of which is currently being contested in good faith by appropriate
proceedings and with respect to which the Company or a Subsidiary, as the case
may be, has established adequate reserves in accordance with GAAP. The Company
knows of no basis for any other tax or assessment that could reasonably be
expected to have a Material Adverse Effect. The charges, accruals and reserves
on the books of the Company and the Subsidiaries in respect of federal, state or
other taxes for all fiscal periods are adequate.

         3.12.    GOVERNMENTAL CONSENT.

         Neither the Company or any Subsidiary thereof, nor the nature of any of
its or their respective businesses or properties, is such so as to require a
consent, approval or authorization of, or filing, registration or qualification
with, any governmental authority on the part of the Company as a condition to
the execution and delivery of this Agreement.

         3.13.    FEES.

         Neither the Company nor any Subsidiary thereof has paid (or promised to
pay) any amendment fee or any other direct or indirect compensation to any
lender, the arranger or the agent party to the Credit Agreement or to any other
creditor of the Company or any Subsidiary (other than the Current Noteholders)
in connection with the transactions contemplated hereby other than a fee of 0.5%
on the outstanding balance as of March 31, 2006, if any, under the Credit
Agreement, and a fee of 0.5% on the outstanding balance as of June 30, 2006, if
any, under the Credit Agreement.

         3.14.    INDEBTEDNESS; LIENS.

         Schedule 3.14 to this Agreement correctly describes all Indebtedness of
the Company and its Subsidiaries as of September 30, 2005. Schedule 3.14 to this
Agreement correctly describes all outstanding Liens securing Indebtedness in an
amount greater than $1,000,000 and all other material Liens on property of the
Company or its Subsidiaries as of the date hereof. Neither the Company nor any
Subsidiary is in default and no waiver of default is currently in effect, in the

<PAGE>

payment of any principal or interest on any Indebtedness of the Company or such
Subsidiary listed on Schedule 3.14 hereto and no event or condition exists with
respect to any Indebtedness of the Company or any Subsidiary listed on such
schedule that would permit (or that with notice or the lapse of time, or both,
would permit) one or more Persons to cause such Indebtedness to become due and
payable before its stated maturity or before its regularly scheduled dates of
payment, other than any such conditions under the Credit Agreement giving rise
to the amendment thereof to be entered into contemporaneously herewith.

4.       AMENDMENTS.

         4.1.     NOTE PURCHASE AGREEMENT AMENDMENTS.

         Subject to the satisfaction of the conditions set forth in Section 5,
the Existing Note Purchase Agreement is hereby and shall be amended in the
manner specified in Exhibit A to this Agreement (the "AMENDMENTS").

         4.2.     NO OTHER AMENDMENTS; CONFIRMATION.

         Except as expressly provided herein, (a) no terms or provisions of any
agreement are modified or changed by this Agreement, (b) the terms of this
Agreement shall not operate as a waiver by any Current Noteholder of, or
otherwise prejudice any Current Noteholder's rights, remedies or powers under,
the Existing Note Purchase Agreement, the Notes or any other Financing Document
or under any applicable law, and (c) the terms and provisions of the Existing
Note Purchase Agreement, the Notes and each other Financing Document shall
continue in full force and effect.

5.       CONDITIONS TO EFFECTIVENESS; POST-CLOSING OBLIGATIONS.

         (a)      Conditions to Effectiveness. This Agreement shall become
effective on November 4, 2005 (the "EFFECTIVE DATE") provided that the Company
and the Required Holders shall have indicated their written consent hereto by
executing and delivering the applicable counterparts of this Agreement in
accordance with Section 17.1 of the Existing Note Purchase Agreement. It is
understood that any Current Noteholder may withhold its consent for any reason
or for no reason, and that, without limitation of the foregoing, any Current
Noteholder hereby makes the granting of its consent contingent upon satisfaction
of each of the following conditions:

                  (i)      the Company shall have entered into and delivered to
         each of the Current Noteholders a true and correct copy of an amendment
         to the Credit Agreement entered into on the date hereof, providing for
         corresponding amendments (as applicable) to the Amendments provided for
         herein, together with all agreements and documents executed in
         connection therewith, in form and substance satisfactory to the Current
         Noteholders;

                  (ii)     the Company shall have pledged to the Collateral
         Agent for the benefit of the holders of Notes and the lenders party to
         the Credit Agreement 65% of each class of the issued and outstanding
         capital stock of each Material Foreign Subsidiary (as defined in the
         Second Amendment Agreement) pursuant to agreements duly executed and
         delivered by it to the Collateral Agent or its counsel, together with
         such other documents

<PAGE>

         as are required under local law to create a valid, enforceable and
         perfected lien on such stock (except that, with respect to the
         Company's Indian Subsidiary, delivery of faxed copies of such documents
         shall have been provided, with a commitment to deliver the originals
         thereof on the next business day) in form and substance satisfactory to
         the Collateral Agent and the Current Noteholders;

                  (iii)    the Company shall have delivered a certificate of one
         of its Senior Financial Officers (A) attaching projections of
         Consolidated EBITDA and Consolidated Capital Expenditures for each
         fiscal quarter of the Company during the Specified Compliance Period,
         (B) acknowledging that such projections are the "Covenant Compliance
         Projections" referred to in the Note Purchase Agreement and (C)
         certifying that such projections contained therein have been prepared
         by the Company on the basis of assumptions which the Company reasonably
         believes are reasonable in light of the historical performance of the
         Company and its Subsidiaries and reasonably foreseeable business
         conditions, in form and substance (including the Covenant Compliance
         Projections) satisfactory to the Current Noteholders;

                  (iv)     the Company shall have delivered legal opinions of
         Miller, Canfield, Paddock and Stone, PLC and of Daryl McDonald, general
         counsel to the Company, with respect to such matters as the Current
         Noteholders may reasonably request and otherwise in form and substance
         satisfactory to them; and

                  (v)      the Company shall have entered into and delivered to
         each of the Current Noteholders a true and correct copy of the
         following, each in form and substance satisfactory to the Current
         Noteholders:

                           (A)      a revised engagement agreement with Bingham
                  McCutchen LLP ("BINGHAM"), special counsel to the Current
                  Noteholders; and

                           (B)      a revised engagement agreement with Conway,
                  Del Genio, Gries & Co. LLC ("CDG"), financial advisor to the
                  Current Noteholders, providing for the engagement of CDG as of
                  October 26, 2005.

         (b)      Post Closing Obligations.

         On or before November 7, 2005, the Company shall have:

                  (i)      in accordance with the terms of the revised
         engagement agreement between Bingham and the Company referred to in
         Section 5(a)(v)(A) above, paid the fee reserve described therein, and
         all unpaid fees and other amounts and disbursements of Bingham for
         which invoices were presented to the Company on or before November 4,
         2005; and

                  (ii)     in accordance with the terms of the revised
         engagement agreement between CDG and the Company referred to above in
         Section 5(a)(v)(B), paid the retainer and initial monthly fee described
         therein, and paid all unpaid fees and other amounts due to CDG and
         shall have reimbursed CDG for all of its reasonable out-of-pocket
         expenses

<PAGE>

         in connection with the transactions contemplated hereby for which
         invoices were presented to the Company on or before November 4, 2005.

         Any amendment entered into in connection with the transaction
contemplated hereby shall be in form and substance satisfactory to the Required
Holders, provided that execution and delivery of this Agreement by the Required
Holders shall be deemed to be an affirmation that such amendment is so
satisfactory.

6.       DEFINED TERMS.

         Capitalized terms used herein and not otherwise defined herein shall
have the meanings ascribed to them in the Note Purchase Agreement.

7.       EXPENSES; FEE.

         (a)      Whether or not any of the Amendments becomes effective, the
Company will promptly (and in any event within thirty (30) days of receiving any
statement or invoice therefor) pay all fees, expenses and costs relating to this
Agreement, including, but not limited to, (i) the reasonable cost of reproducing
this Agreement and the other documents delivered in connection herewith, (ii)
the reasonable fees and other amounts and disbursements of Bingham, incurred in
connection with the preparation, negotiation and delivery of this Agreement and
the documents contemplated hereby, to the extent not paid pursuant to Section
5(f) above and (iii) the fees and other amounts and disbursements of CDG. This
Section 7 shall not be construed to limit the Company's obligations under
Section 15.1 of the Note Purchase Agreement.

         (b)      In consideration of the Amendments provided herein, the
Company shall pay to each holder of Notes a fee, on March 31, 2006, equal to 1%
of the aggregate outstanding principal amount of Notes held by such holder on
such date, in each case payable by wire transfer of immediately available funds
to the account and in accordance with the instructions for payments in respect
of the Notes held by such holder set forth in Schedule A to the Note Purchase
Agreement, or in accordance with such other instructions provided by such holder
to the Company in writing.

<PAGE>

8.       MISCELLANEOUS.

         8.1.     ACKNOWLEDGEMENT OF INTEREST RATE.

         The Company hereby acknowledges and agrees that, prior to giving effect
to this Agreement, it was not in compliance with Section 10.14 of the Note
Purchase Agreement and therefore has not met the Applicable Rate Reduction
Criteria, and that, as a result of such non-compliance, the Applicable Interest
Rate under the Note Purchase Agreement is and shall remain 6.60% per annum.
Notwithstanding the foregoing, the Current Noteholders acknowledge and affirm
that for purposes of determining the "Remaining Scheduled Payments" (as defined
in Section 8.7 of the Note Purchase Agreement) with respect to any Note in
determining the Make-Whole Amount with respect thereto, such determination shall
be made assuming the Applicable Interest Rate were 4.66% per annum, as agreed in
the Second Amendment Agreement.

         8.2.     WAIVERS.

         (a)      Conditional Waiver. The Current Noteholders hereby agree that
if an Event of Default exists and a lender or lenders, or group of lenders,
contemplating making a loan or loans to the Company requires as the sole
remaining condition to funding such loan or loans that the Current Noteholders
waive such Event of Default, then the Current Noteholders will, without
compensation, provide such a waiver, but only if the Notes are paid in full
(including accrued interest and any applicable Make-Whole Amount) from the
proceeds of such loan or loans contemporaneously with the giving of such waiver.

         (b)      Credit Agreement Leverage Ratio. The Current Noteholders
hereby agree that the leverage ratio (the "EXISTING BANK LEVERAGE RATIO") set
forth in Section 6.19.2 of the Credit Agreement prior to giving effect to the
Second Amendment to Credit Agreement, dated as of the date hereof, between the
Company and the lenders party to the Credit Agreement (the "SECOND CREDIT
AGREEMENT AMENDMENT"), which was deemed to be incorporated into the Note
Purchase Agreement pursuant to Section 10.15 thereof (the "MOST FAVORED LENDER
COVENANT") shall be deemed to be removed from the Note Purchase Agreement. For
the avoidance of doubt, the deemed removal of the Existing Bank Leverage Ratio
from the Note Purchase Agreement shall in no way limit the operation of the Most
Favored Lender Covenant to any other provision of any More Favorable Lending
Agreement, including without limitation, the leverage ratio (the "NEW BANK
LEVERAGE RATIO") set forth in Section 6.19.2 of the Credit Agreement, after
giving effect to the Second Credit Agreement Amendment, which ratio shall be
deemed to be incorporated into the Note Purchase Agreement under the Most
Favored Lender Covenant.

         8.3.     FURTHER ASSURANCES.

         Without in any way limiting the obligations of the Company and its
Subsidiaries under the Security Agreement, the Company and its Subsidiaries
shall take all further commercially reasonable action requested by the
Collateral Agent or the Current Noteholders to create valid, enforceable and
perfected liens in favor of the Collateral Agent on 65% of each class of the
issued and outstanding capital stock of each Material Foreign Subsidiary.

<PAGE>

         8.4.     PART OF NOTE PURCHASE AGREEMENT, FUTURE REFERENCES, ETC.

         This Agreement shall be construed in connection with and as a part of
the Existing Note Purchase Agreement and, except as expressly amended by this
Agreement, all terms, conditions and covenants contained in the Existing Note
Purchase Agreement, the Notes and the other Financing Documents are hereby
ratified and shall be and remain in full force and effect. Any and all notices,
requests, certificates and other instruments executed and delivered after the
execution and delivery of this Agreement may refer to the Note Purchase
Agreement without making specific reference to this Agreement, but nevertheless
all such references shall include this Agreement unless the context otherwise
requires.

         8.5.     GOVERNING LAW.

         THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND ENFORCED IN
ACCORDANCE WITH, THE LAW OF THE STATE OF MICHIGAN, UNITED STATES OF AMERICA,
EXCLUDING CHOICE-OF-LAW PRINCIPLES OF THE LAW OF SUCH STATE THAT WOULD REQUIRE
THE APPLICATION OF THE LAWS OF A JURISDICTION OTHER THAN SUCH STATE.

         8.6.     DUPLICATE ORIGINALS, EXECUTION IN COUNTERPART.

         Two (2) or more duplicate originals hereof may be signed by the
parties, each of which shall be an original but all of which together shall
constitute one and the same instrument. This Agreement may be executed in one or
more counterparts and shall become effective at the time provided in Section 5
hereof, and each set of counterparts that, collectively, show execution by the
Company and each consenting Current Noteholder shall constitute one duplicate
original.

         8.7.     BINDING EFFECT.

         This Agreement shall be binding upon and shall inure to the benefit of
the Company and the Current Noteholders and their respective successors and
assigns.

   [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK; NEXT PAGE IS SIGNATURE PAGE.]

<PAGE>

         If this Agreement is satisfactory to you, please so indicate by signing
the applicable acceptance on a counterpart hereof and returning such counterpart
to the Company, whereupon this Agreement shall become binding among the Company
and you in accordance with its terms.

                                         Very truly yours,

                                         TECUMSEH PRODUCTS COMPANY

                                         By:    /s/ James S. Nicholson
                                         Name:  James S. Nicholson
                                         Title: Vice President, Treasurer & CFO

Accepted:

NEW YORK LIFE INSURANCE COMPANY

By:    /s/ Lisa A. Scuderi
Name:  Lisa A. Scuderi
Title: Investment Vice President

NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION
BY:      NEW YORK LIFE INVESTMENT MANAGEMENT LLC, ITS INVESTMENT MANAGER

By:    /s/ Lisa A. Scuderi
Name:  Lisa A. Scuderi
Title: Investment Vice President

NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION
  INSTITUTIONALLY OWNED LIFE INSURANCE SEPARATE ACCOUNT
BY:      NEW YORK LIFE INVESTMENT MANAGEMENT LLC, ITS INVESTMENT MANAGER

By:    /s/ Lisa A. Scuderi
Name:  Lisa A. Scuderi
Title: Investment Vice President

         [Signature Page to Amendment No. 3 to Note Purchase Agreement]

<PAGE>

STATE FARM LIFE INSURANCE COMPANY

By:    /s/ Jeffrey Attwood
Name:  Jeffrey Attwood
Title: Investment Officer

By:    /s/ Larry Rottunda
Name:  Larry Rottunda
Title: Assistant Secretary

STATE FARM LIFE AND ACCIDENT ASSURANCE COMPANY

By:    /s/ Jeffrey Attwood
Name:  Jeffrey Attwood
Title: Investment Officer

By:    /s/ Larry Rottunda
Name:  Larry Rottunda
Title: Assistant Secretary

GENERAL ELECTRIC CAPITAL ASSURANCE COMPANY

By:    /s/ Morian C. Mooers
Name:  Morian C. Mooers
Title: Investment Officer

GE CAPITAL LIFE ASSURANCE COMPANY OF NEW YORK

By:    /s/ Morian C. Mooers
Name:  Morian C. Mooers
Title: Investment Officer

EMPLOYERS REINSURANCE CORPORATION
BY:      GE ASSET MANAGEMENT INCORPORATED, ITS INVESTMENT MANAGER
BY:      GENWORTH FINANCIAL ASSET MANAGEMENT, LLC, ITS INVESTMENT ADVISOR

By:    /s/ Morian C. Mooers
Name:  Morian C. Mooers
Title: Investment Officer

<PAGE>

FIRST COLONY LIFE INSURANCE COMPANY

By:    /s/ Morian C. Mooers
Name:  Morian C. Mooers
Title: Investment Officer

GE LIFE AND ANNUITY ASSURANCE COMPANY

By:    /s/ Morian C. Mooers
Name:  Morian C. Mooers
Title: Investment Officer

GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY

By:    /s/ Tad Anderson
Name:  Tad Anderson
Title: Ass't. Vice President, Investments

By:    /s/ J.G. Lowery
Name:  J.G. Lowery
Title: Ass't. Vice President, Investments

LONDON LIFE AND CASUALTY (BARBADOS) CORPORATION
BY:      ORCHARD CAPITAL MANAGEMENT, LLC, AS INVESTMENT ADVISER

By:    /s/ Wayne Hoffmann
Name:  Wayne Hoffmann
Title: Senior Vice President, Investments

By:    /s/ Tad Anderson
Name:  Tad Anderson
Title: Ass't. Vice President, Investments

<PAGE>

LONDON LIFE INSURANCE COMPANY

By:    /s/ W.J. Sharman
Name:  W.J. Sharman
Title: Authorized Signatory

By:    /s/ D.B. Bergen
Name:  D.B. Bergen
Title: Authorized Signatory

THE GREAT-WEST LIFE ASSURANCE COMPANY

By:    /s/ W.J. Sharman
Name:  W.J. Sharman
Title: Authorized Signatory

By:    /s/ D.B. Bergen
Name:  D.B. Bergen
Title: Authorized Signatory

PACIFIC LIFE INSURANCE COMPANY
(NOMINEE:  MAC & CO.)

By:    /s/ Cathy Schwartz
Name:  Cathy Schwartz
Title: Assistant Vice President

By:    /s/ David C. Patch
Name:  David C. Patch
Title: Assistant Secretary

JEFFERSON-PILOT LIFE INSURANCE COMPANY

By:
   ----------------------------------
Name:
Title:

<PAGE>

JEFFERSON PILOT FINANCIAL INSURANCE COMPANY

By:
   ----------------------------------
Name:
Title:

JEFFERSON PILOT LIFEAMERICA INSURANCE COMPANY

By:
   ----------------------------------
Name:
Title:

MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY
BY:      BABSON CAPITAL MANAGEMENT LLC, AS INVESTMENT ADVISER

By:    /s/ Elisabeth A. Perenick
Name:  Elisabeth A. Perenick
Title: Managing Director

C.M. LIFE INSURANCE COMPANY
BY:      BABSON CAPITAL MANAGEMENT LLC, AS INVESTMENT SUB-ADVISER

By:    /s/ Elisabeth A. Perenick
Name:  Elisabeth A. Perenick
Title: Managing Director

MASSMUTUAL ASIA LIMITED
BY:      BABSON CAPITAL MANAGEMENT LLC, AS INVESTMENT ADVISER

By:    /s/ Elisabeth A. Perenick
Name:  Elisabeth A. Perenick
Title: Managing Director

<PAGE>

ALLSTATE LIFE INSURANCE COMPANY

By:    /s/ Robert B. Bodett
Name:  B. Bodett

By:    /s/ Jerry D. Zinkula
Name:  Jerry D. Zinkula

Authorized Signatories

ALLSTATE LIFE INSURANCE COMPANY OF NEW YORK

By:    /s/ Robert B. Bodett
Name:  B. Bodett

By:    /s/ Jerry D. Zinkula
Name:  Jerry D. Zinkula

Authorized Signatories

AMERICAN HERITAGE LIFE INSURANCE COMPANY

By:    /s/ Robert B. Bodett
Name:  B. Bodett

By:    /s/ Jerry D. Zinkula
Name:  Jerry D. Zinkula

Authorized Signatories

NATIONWIDE LIFE INSURANCE COMPANY
NATIONWIDE LIFE AND ANNUITY INSURANCE COMPANY
NATIONWIDE MUTUAL INSURANCE COMPANY

By:    /s/ Mark W. Poeppelman
Name:  Mark W. Poeppelman
Title: Authorized Signatory

<PAGE>

TRANSAMERICA LIFE INSURANCE COMPANY

By:    /s/ Bill Henricksen
Name:  Bill Henricksen
Title: Vice President

TRANSAMERICA OCCIDENTAL LIFE INSURANCE COMPANY

By:    /s/ Bill Henricksen
Name:  Bill Henricksen
Title: Vice President

HARTFORD LIFE INSURANCE COMPANY, AND
HARTFORD UNDERWRITERS INSURANCE COMPANY
BY:      HARTFORD INVESTMENT SERVICES, INC., AS AGENT AND ATTORNEY-IN-FACT

By:    /s/ Ronald A. Mendel
Name:  Ronald A. Mendel
Title: Managing Director

AMERICAN UNITED LIFE INSURANCE COMPANY

By:    /s/ Michael Bullock
Name:  Michael Bullock
Title: V.P. Private Placements

PIONEER MUTUAL LIFE INSURANCE COMPANY
BY:      AMERICAN UNITED LIFE INSURANCE COMPANY, ITS AGENT

By:    /s/ Michael Bullock
Name:  Michael Bullock
Title: V.P. Private Placements

<PAGE>

THE STATE LIFE INSURANCE COMPANY
BY:      AMERICAN UNITED LIFE INSURANCE COMPANY, ITS AGENT

By:    /s/ Michael Bullock
Name:  Michael Bullock
Title: V.P. Private Placements

AMERITAS LIFE INSURANCE CORP.
BY:      AMERITAS INVESTMENT ADVISORS, INC., AS AGENT

By:    /s/ Andrew S. White
Name:  Andrew S. White
Title: Vice President, Fixed Income Securities

ACACIA NATIONAL LIFE INSURANCE COMPANY
BY:      AMERITAS INVESTMENT ADVISORS, INC., AS AGENT

By:    s/ Andrew S. White
Name:  Andrew S. White
Title: Vice President, Fixed Income Securities

AMERITAS VARIABLE LIFE INSURANCE COMPANY
BY:      AMERITAS INVESTMENT ADVISORS, INC., AS AGENT

By:    /s/ Andrew S. White
Name:  Andrew S. White
Title: Vice President, Fixed Income Securities

<PAGE>

         The undersigned Guarantors hereby acknowledge and agree to the terms
and provisions contained herein, agree to be bound by the terms of Section 4
hereof, and consent to the Company's execution hereof:

CONVERGENT TECHNOLOGIES INTERNATIONAL, INC.
DOUGLAS HOLDINGS, INC.
EVERGY, INC.
FASCO INDUSTRIES, INC.
LITTLE GIANT PUMP CO.
MANUFACTURING DATA SYSTEMS, INC.
MP PUMPS, INC.
TECUMSEH CANADA HOLDING COMPANY
TECUMSEH COMPRESSOR COMPANY
TECUMSEH INVESTMENTS INC.
TECUMSEH POWER COMPANY
TECUMSEH PUMP COMPANY
VON WEISE GEAR COMPANY
TECUMSEH DO BRAZIL USA, LLC

By:    /s/ James S. Nicholson
Name:  James S. Nicholson
Title: Vice President and Treasurer

EUROMOTOR, INC.

By:    /s/ James S. Nicholson
Name:  James S. Nicholson
Title: Vice President

HAYTON PROPERTY COMPANY, LLC
BY:      TECUMSEH PRODUCTS COMPANY, ITS SOLE MEMBER

By:    /s/ James S. Nicholson
Name:  James S. Nicholson
Title: Vice President, Treasurer
       and Chief Financial Officer

<PAGE>

                                     ANNEX 1

                    CURRENT NOTEHOLDERS AND PRINCIPAL AMOUNTS

<Table>
<Caption>
NAME OF CURRENT NOTEHOLDER                                                           OUTSTANDING PRINCIPAL AMOUNT OF
                                                                                         NOTES HELD AT JUNE 30, 2005
----------------------------------------------------------------                     -------------------------------
<S>                                                                                  <C>
New York Life Insurance Company                                                                       $23,333,333.33
New York Life Insurance and Annuity Corporation                                                       $13,750,000.00
New York Life Insurance and Annuity Corporation                                                          $416,666.66
    Institutionally Owned Life Insurance Separate Account
State Farm Life Insurance Company                                                                     $31,666,666.67
State Farm Life and Accident Assurance Company                                                         $1,666,666.67
Hare & Co.                                                                                            $12,500,000.00
  (as nominee for General Electric Capital Assurance Company)
Hare & Co.                                                                                             $4,166,666.67
  (as nominee for GE Capital Life Assurance Company of New York)
Cudd & Co.                                                                                             $4,166,666.67
  (as nominee for Employers Reinsurance Corporation)
Hare & Co.                                                                                             $4,166,666.67
  (as nominee for First Colony Life Insurance Company)
Hare & Co.                                                                                             $4,166,666.67
  (as nominee for GE Life and Annuity Assurance Company)
Great-West Life & Annuity Insurance Company                                                           $12,500,000.00
London Life Insurance Company                                                                          $8,333,333.33
Mac & Co.                                                                                              $4,166,666.67
  (as nominee for The Great-West Life Assurance Company)
London Life and Casualty (Barbados) Corporation                                                        $4,166,666.67
Mac & Co. (as nominee for Pacific Life Insurance Company)                                             $20,833,333.33
Jefferson-Pilot Life Insurance Company                                                                 $7,500,000.00
Jefferson Pilot Financial Insurance Company                                                            $5,833,333.33
Jefferson Pilot Life America Insurance Company                                                         $3,333,333.34
Massachusetts Mutual Life Insurance Company                                                           $13,583,333.32
C.M. Life Insurance Company                                                                            $2,666,666.67
Gerlach & Co.                                                                                            $416,666.67
  (as nominee for MassMutual Asia)
Allstate Life Insurance Company                                                                       $10,000,000.00
</Table>

                                    Annex 1-1
<PAGE>
<Table>
<Caption>
NAME OF CURRENT NOTEHOLDER                                                           OUTSTANDING PRINCIPAL AMOUNT OF
                                                                                         NOTES HELD AT JUNE 30, 2005
----------------------------------------------------------------                     -------------------------------
<S>                                                                                  <C>
Allstate Life Insurance Company of New York                                                            $4,166,667.00
American Heritage Life Insurance Company                                                               $2,500,000.00
Nationwide Life Insurance Company                                                                      $7,500,000.00
Nationwide Life and Annuity Insurance Company                                                          $6,250,000.00
Nationwide Mutual Insurance Company                                                                    $2,916,666.67
Transamerica Life Insurance Company                                                                    $9,375,000.00
Transamerica Occidental Life Insurance Company                                                         $3,125,000.00
Hartford Life Insurance Company                                                                        $6,666,666.66
Hartford Underwriters Insurance Company                                                                $3,333,333.33
American United Life Insurance Company                                                                 $6,250,000.00
Pioneer Mutual Life Insurance Company                                                                    $625,000.00
The State Life Insurance Company                                                                         $625,000.00
Ameritas Life Insurance Corp.                                                                          $1,666,666.67
Chimebridge & Company                                                                                    $833,333.33
  (as nominee for Acacia National Life Insurance Company)
Ameritas Variable Life Insurance Company                                                                 $833,333.33
</Table>

                                    Annex 1-2
<PAGE>

                                  SCHEDULE 3.14

                         EXISTING INDEBTEDNESS AND LIENS

                                [TO BE ATTACHED]

                                 Schedule 3.14-1
<PAGE>

                                                                      EXHIBIT A

                 AMENDMENTS TO EXISTING NOTE PURCHASE AGREEMENT

1.       Section 7.1(a) of the Existing Note Purchase Agreement is hereby
         amended by deleting the first three lines thereof and replacing them
         with the following:

                  "(a)     Quarterly Statements - with respect to each quarterly
         fiscal period in each fiscal year of the Company, on the earlier of (x)
         the date the Company files its Quarterly Report on Form 10-Q with the
         Securities and Exchange Commission and (y) 40 days after the end of
         such quarterly fiscal period, beginning with the quarterly fiscal
         period ending December 31, 2005, duplicate copies of:"

2.       Section 7.1(h)(i) of the Existing Note Purchase Agreement is hereby
         amended by adding "(1)" after the phrase "which sets forth in
         reasonable detail" in the third line thereof and adding the following
         to the end of such Section, immediately prior to the semi-colon:

                  ", and (2) a calculation of Consolidated EBITDA for the period
                  of 12 fiscal months of the Company ending on the last day of
                  such fiscal month and for the period beginning on the first
                  day of the then current fiscal year of the Company and ending
                  on the last day of such fiscal month"

3.       Section 8.8(a) of the Existing Note Purchase Agreement is hereby
         amended by deleting the amount "$15,000,000" appearing in the fifth
         line thereof and replacing it with "$7,500,000".

4.       Section 10.10(e) of the Existing Note Purchase Agreement is hereby
         amended by deleting the amount "$15,000,000" appearing in the fifth
         line thereof and replacing it with "$7,500,000".

5.       Section 10.13 of the Existing Note Purchase Agreement is hereby amended
         to read in its entirety as follows:

                  "Section 10.13. Bank Credit Facility.

                           (a)      The Company will not, at any time, permit
                  the aggregate commitment of the Lenders under its Primary
                  Credit Facility to be less than $75,000,000.

                           (b)      The Company will not permit the aggregate
                  commitment of the Lenders under its Primary Credit Facility,
                  or the aggregate principal amount of Indebtedness outstanding
                  thereunder, to be:

                                    (i)      greater than $100,000,000 at any
                           time during the Specified Compliance Period; and

                                    (ii)     greater than $200,000,000 at any
                           other time.

                                   Exhibit A-1
<PAGE>

                           (c)      The Company and its Subsidiaries will be
                  permitted to (and shall, on or prior to December 21, 2009)
                  refinance the credit facilities provided under the Credit
                  Agreement, but shall do so only in accordance with the terms
                  of the Intercreditor Agreement."

6.       Section 12.2 of the Existing Note Purchase Agreement is hereby amended
         by adding the following proviso immediately prior to the period at the
         end of such Section:

                  "; provided, however, that the rights of each holder of Notes
                  with respect to any collateral securing the Notes for which a
                  Lien has been granted to the Collateral Agent, and any other
                  rights, powers and remedies under any of the Security
                  Documents, shall be exercised solely in accordance with the
                  terms of the Intercreditor Agreement"

7.       The definition of "Initial Projections" appearing in Schedule B to the
         Existing Note Purchase Agreement is hereby deleted, and each reference
         to the "Initial Projections" in the Existing Note Purchase Agreement
         shall be deemed to be a reference to the "Covenant Compliance
         Projections" (as defined below in Section 10 of this Exhibit A).

8.       The definition of "Permitted Senior Secured Debt" appearing in Schedule
         B to the Existing Note Purchase Agreement is hereby amended and
         restated to read in its entirety as follows:

                  "Permitted Senior Secured Debt" shall have the meaning
         ascribed to the term "Secured Obligations" in the Intercreditor
         Agreement."

9.       The definition of "Projected Consolidated EBITDA" appearing in Schedule
         B to the Existing Note Purchase Agreement is hereby amended by deleting
         the references to "Required Business Percentage" and "Required
         Securitization Segments Percentage" and replacing such references with
         "Remaining Business Percentage" and "Remaining Securitization Segments
         Percentage", respectively.

10.      The definition of "Specified Covenant Reversion Condition" appearing in
         Schedule B to the Existing Note Purchase Agreement is hereby amended
         and restated in its entirety to read as follows:

                  ""Specified Covenant Reversion Condition" means compliance by
         the Company in all respects with the terms and conditions of this
         Agreement at all times during the period beginning on (and including)
         the Second Amendment Effective Date and ending on (and including)
         December 31, 2006, without giving effect to any non-compliance by the
         Company with the terms of Section 10.14 of the Agreement prior to the
         effectiveness of the Third Amendment other than for purposes of
         determining if the Applicable Rate Reduction Criteria have been met."

11.      The following new definitions are hereby added to Schedule B of the
         Existing Note Purchase Agreement to appear in their appropriate
         alphabetical places:

                                   Exhibit A-2
<PAGE>

                  ""Covenant Compliance Projections" means the projections of
         Consolidated EBITDA and Consolidated Capital Expenditures delivered to
         the holders of the Notes pursuant to Section 5(c) of the Third
         Amendment."

                  ""Third Amendment" means Amendment No. 3 to Note Purchase
         Agreement dated as of November 4, 2005 by and among the Company and the
         Required Holders."

                                   Exhibit A-3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00092-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00092-of-00352.parquet"}]]